Mangangot, Mark Caleb R.

HRN: 24-14-40  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/04/2026
CEFTAZIDIME 1GM (VIAL)
02/04/2026
02/11/2026
IV
300mg
Q8h
PCAP-C
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: